Literature DB >> 8778258

Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease.

M A Hely1, W G Reid, G M Halliday, D A McRitchie, J Leicester, R Joffe, W Brooks, G A Broe, J G Morris.   

Abstract

OBJECTIVE: To further elucidate the relation between diffuse Lewy body disease and Parkinson's disease. METHODS AND
RESULTS: The clinical features of nine cases of pure diffuse Lewy body disease without pathological evidence of coexisting Alzheimer's neuritic pathology were reported. All patients were aged less than 70 years at onset (mean 62 years). Five patients presented with clinical features, which included assymetric resting tremor had levodopa responsiveness, which were initially indistinguishable from idiopathic Parkinson's disease. All five patients later became demented (mean of three years after presentation). Two further patients presented with parkinsonism and dementia and two patients presented with dementia and developed parkinsonism at a later stage. Hallucinations appeared 2.5-9 years after the onset of symptoms in six patients and were a presenting feature in one patient. All patients met the pathological criteria of idiopathic Parkinson's disease, with respect to the midbrain changes, in addition to having diffuse cortical Lewy bodies.
CONCLUSIONS: Diffuse Lewy body disease may present a parkinsonism, dementia, or both depending on whether the Lewy body pathology begins in the midbrain, the cortex, or both together. When it begins in the midbrain, diffuse Lewy body disease is indistinguishable initially from idiopathic Parkinson's disease. Diffuse Lewy body disease may be a common cause of dementia complicating Parkinson's disease.

Entities:  

Mesh:

Year:  1996        PMID: 8778258      PMCID: PMC486366          DOI: 10.1136/jnnp.60.5.531

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  42 in total

1.  A woman with dementia and parkinsonism unresponsive to levodopa.

Authors:  R Pamphlett; J Morris; J Leicester
Journal:  Med J Aust       Date:  1988-11-07       Impact factor: 7.738

2.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

3.  An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type.

Authors:  I G McKeith; A F Fairbairn; R A Bothwell; P B Moore; I N Ferrier; P Thompson; R H Perry
Journal:  Neurology       Date:  1994-05       Impact factor: 9.910

4.  What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis.

Authors:  J Jankovic; A H Rajput; L I Golbe; J C Goodman
Journal:  Mov Disord       Date:  1993-10       Impact factor: 10.338

5.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

Authors:  G K Wenning; Y Ben Shlomo; M Magalhães; S E Daniel; N P Quinn
Journal:  Brain       Date:  1994-08       Impact factor: 13.501

6.  Antemortem diagnosis of diffuse Lewy body disease.

Authors:  H A Crystal; D W Dickson; J E Lizardi; P Davies; L I Wolfson
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

7.  Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.

Authors:  R H Perry; D Irving; G Blessed; A Fairbairn; E K Perry
Journal:  J Neurol Sci       Date:  1990-02       Impact factor: 3.181

8.  A pathological study of the association between Lewy body disease and Alzheimer's disease.

Authors:  W R Gibb; C Q Mountjoy; D M Mann; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

9.  Depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; P L Bolduc; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1990-01       Impact factor: 2.254

10.  Alzheimer's disease and Lewy body disease: a comparative clinicopathological study.

Authors:  C F Lippa; T W Smith; J M Swearer
Journal:  Ann Neurol       Date:  1994-01       Impact factor: 10.422

View more
  13 in total

1.  Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease.

Authors:  D E Riley; T C Chelimsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography.

Authors:  Z Walker; D C Costa; A G Janssen; R W Walker; G Livingstone; C L Katona
Journal:  Eur J Nucl Med       Date:  1997-06

3.  Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease.

Authors:  J Calderon; R J Perry; S W Erzinclioglu; G E Berrios; T R Dening; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-02       Impact factor: 10.154

Review 4.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 5.  Electroencephalogram in dementia with Lewy bodies: a systematic review.

Authors:  Simela Chatzikonstantinou; Jack McKenna; Eleni Karantali; Fivos Petridis; Dimitrios Kazis; Ioannis Mavroudis
Journal:  Aging Clin Exp Res       Date:  2020-05-07       Impact factor: 3.636

Review 6.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

7.  A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.

Authors:  M Yoshita; J Taki; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

8.  Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer's type: a comparative neuropsychological study and literature review.

Authors:  M A Lambon Ralph; J Powell; D Howard; A B Whitworth; P Garrard; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-02       Impact factor: 10.154

Review 9.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 10.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.